ENTITY
China Biologic Products

China Biologic Products (CBPO US)

28
Analysis
Health Care • United States
China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.
more
bullish•51 Job Inc Adr
•18 Sep 2020 15:34

You're Hired! DCP's Proposal For 51job.Inc.

Sina Corp (Class A) (SINA US) looks sets to join the growing list of Chinese companies seeking to delist in the US and relist, ostensibly in Hong...

Logo
627 Views
Share
bullish•Sogou Inc
•28 Jul 2020 12:28

Sogou/Tencent: The Latest Chinese Internet Privatisation

Chinese search-engine Sogou Inc (SOGO US), majority-owned by Sohu.com Inc (SOHU US)  and Tencent Holdings (700 HK), has announced it has received a...

Logo
634 Views
Share
•07 Jul 2020 14:10

Sina Corp: Management Buyout Offer

Sina Corp (Class A) (SINA US) looks sets to join the growing list of Chinese companies seeking to delist in the US and relist, ostensibly in Hong...

Logo
798 Views
Share
•30 Apr 2020 10:28

(Mostly) Asia M&A: April 2020 Roundup

For the month of April, just six new deals were discussed on Smartkarma with an overall announced deal size of ~US$9.4bn. Clicking on the...

Logo
809 Views
Share
•11 Mar 2020 20:32

China Biologic Products Privatisation: Share Price Gains from a Potential Deal Seem Priced In

It was reported by Bloomberg and several other news media outlets that a Chinese buyout group is in advanced talks to take China Biologic Products...

Share
x